A role for thrombin in the initiation of the immune response to therapeutic factor VIII

Factor VIII Inhibitors: Risk Factors and Methods for Prevention and Immune Modulation

(2009) Ai Hong Zhang et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Mechanism of action of clinically approved adjuvants

(2009) Bart N Lambrecht et al.   CURRENT OPINION IN IMMUNOLOGY

Inhibitor incidence with recombinant vs. plasma-derived FVIII in previously untreated patients with severe hemophilia A: homogeneous results from four published observational studies

(2009) T. CALVEZ et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The molecular mechanisms of immunomodulation and tolerance induction to factor VIII

(2009) B. WATERS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A Recombinant Peptide, Hirudin, Potentiates the Inhibitory Effects of Stealthy Liposomal Vinblastine on the Growth and Metastasis of Melanoma

(2008) Rong-Rong Guo et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer

(2008) Simon N. Waddington et al.   CELL

Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1–dependent leukocyte recruitment in vivo

(2008) Daxin Chen et al.   JOURNAL OF EXPERIMENTAL MEDICINE